Articles

Podcasts

Videos

Clinical

The meta-analysis included 6 studies, of which 5 were conducted in sub-Saharan Africa, showed that the diagnostic accuracy for Xpert testing was similar to the former symptom screening and rapid test format.  

All HIV Patients Should be Tested for Tuberculosis in High-Burden Areas

April 10 is a day that commemorates a population group that is emerging in terms of increased incidence rates, and needs help with inherent challenges including medication adherence and understanding of the disease. 

National Youth HIV and AIDS Awareness Day is an Opportunity to Celebrate Strides, Educate These Populations 

In Germany, HIV pre-exposure prophylaxis users are recommended to receive regular HIV, STI, and renal function testing. How frequently are PrEP users getting tested? 

PrEP User Adherence to Regular HIV Testing Recommendations

Using CRISPR technology, investigators were able to “knock out” primary human CD4+ T cells, identifying new genes essential to HIV viral replication.

CRISPR Technique Identifies New Genes Affecting HIV Infection

A meta-analysis showed that computerized cognitive training programs produced significant improvements in 6 cognitive and daily function domains among adults living with HIV. 

Computerized Cognitive Training Benefits HIV Patients

The study authors wrote that selection bias at transmission can shape HIV disease severity and tolerance in different groups. 

HIV Virulence Stronger in Heterosexual Men

Today, the FDA approved the abacavir, dolutegravir, and lamivudine single tablet formulation Triumeq, a once-daily HIV treatment for children.

FDA Approves Triumeq, ViiV Healthcare's Daily Treatment for Children Living With HIV

Today, the FDA approved the long-acting HIV treatment Cabenuva (cabotegravir and rilpivirine dually administered) for virologically suppressed adolescents 12 years and older. 

HIV Treatment Cabenuva Now Available for Adolescents 12 and Older

Tori Pipak, a physician assistant at Allegheny Health Network’s Positive Health Clinic, details the comprehensive services the clinic provides to people living with HIV.

The Positive Health Clinic: Holistic Care for People Living With HIV

With FDA Approval, the oral lead-in for the cabotegravir and rilpivirine long-acting HIV treatment (Cabenuva) is now optional. Clinical trial data showed similar safety and efficacy profiles for initiating the therapy with or without the oral lead-in.

SEXUALLY TRANSMITTED DISEASES

Latest News